Inactive
Total Small Business Set-Aside (FAR 19.5)
Notice ID:75N95C20Q00007
The National Center for the Advancement of Translational Sciences has a requirement for; Contractor shall synthesize/make 6 compounds following their internal protocol. NCATS ETB is requesting the fol...
The National Center for the Advancement of Translational Sciences has a requirement for; Contractor shall synthesize/make 6 compounds following their internal protocol. NCATS ETB is requesting the following compounds be made: 1. ML152, 100 mg CAS 669718-48-3 Version 11-30-2016-1 FAR Part 11—Describing Agency Needs 2. ML155, 100 mg CAS 1090708-11-4 3. ML168, 100 mg CAS 571149-48-9 4. ML202, 100 mg CAS 1221186-52-2 5. ML206, 100 mg CAS 1439376-13-2 6. ML008, 100 mg CAS 442898-34-2 - Purity >95% for each compound - NMR, hi-res mass spec included for each compound - CoA and SDS included for each compound